نتایج جستجو برای: hbsag immune epitopes

تعداد نتایج: 289300  

Journal: :Antiviral therapy 2013
Grace L-H Wong Henry L-Y Chan Angeline O-S Lo Hoi-Yun Chan Chi-Hang Tse Angel M-L Chim Vincent W-S Wong

BACKGROUND Kinetics of serum hepatitis B surface antigen (HBsAg) level in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B patients presented with severe reactivation and received oral antiviral therapy is unknown. We aimed to investigate the kinetics of HBsAg level among these patients. METHODS HBeAg-negative patients on antiviral therapy with follow-up for 2 years were studied. Th...

Journal: :Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2014
Michael Platt Sonam Dilwali Alphi Elackattu Jignesh R Parikh Konstantina M Stankovic

Etiologies for many inner ear disorders, including autoimmune inner ear disease, sudden sensorineural hearing loss, and Meniere's disease, remain unknown. Indirect evidence suggests an immune-mediated process involving an allergic or autoimmune mechanism. We examined whether known immunogenic proteins share sequence similarity with inner ear proteins, which may lead to cross-reactivity and detr...

2003
Joel D. Meyers

Twenty patients who were positive for hepatitis B surface antigen (HBsAg) underwent allogeneic marrow transplant for malignancy or other underlying hematologic disease between 1975 and 1986. After transplant, one patient had serologic evidence of hepatitis B virus (HBV) reactivation whereas three patients had evidence of an immune response to HBV. Among four patients with serologic follow-up of...

Objective(s):Brucellosis is a well-known domestic animal infectious disease, which is caused by Brucella bacterium. GroEL antigen increases Brucella survival and is one of the major antigens that stimulates the immune system. Hence, the objective of the present study was cloning and bioinformatics analysis of GroEL gene. Materials and Methods: The full-length open reading frame of this gene was...

Journal: :Journal of immunology 2005
Chutima Kumkhaek Kooruethai Phra-Ek Laurent Rénia Pratap Singhasivanon Sornchai Looareesuwan Chakrit Hirunpetcharat Nicholas J White Alan Brockman Anne Charlotte Grüner Nicolas Lebrun Ali Alloueche François Nosten Srisin Khusmith Georges Snounou

Protective cellular immune responses depend on MHC presentation of pathogen-derived Ag fragments. MHC diversity renders this process sensitive to point mutations coding for altered amino acid sequence of the short target Ag-derived peptides epitopes. Thus, in a given host, a pathogen with an altered epitope sequence will be more likely to escape detection and elimination by the immune system. A...

2012
Niamh M. Keane Steven G. Roberts Coral-Ann M. Almeida Tanya Krishnan Abha Chopra Emma Demaine Rebecca Laird Monika Tschochner Jonathan M. Carlson Simon Mallal David Heckerman Ian James Mina John

HIV-1 mutations, which reduce or abolish CTL responses against virus-infected cells, are frequently selected in acute and chronic HIV infection. Among population HIV-1 sequences, immune selection is evident as human leukocyte antigen (HLA) allele-associated substitutions of amino acids within or near CD8 T-cell epitopes. In these cases, the non-adapted epitope is susceptible to immune recogniti...

Journal: :Cancer research 1999
D C LaTemple J T Abrams S Y Zhang U Galili

A major prerequisite for the success of tumor vaccines is their effective uptake by antigen-presenting cells (APCs) and transport of these APCs to the draining lymph nodes, where the processed and presented tumor-associated antigens activate tumor-specific naive T cells. We previously suggested that the immunogenicity of autologus tumor vaccines in humans may be augmented by engineering vaccina...

Journal: :Indian Journal of Pharmaceutical Sciences 2021

Contagious human coronavirus belong to family Coronaviridae and infects respiratory system causing the disease known as COVID-19 (WHO). To eradicate severe acute syndrome 2 pandemic, an effective vaccine should be developed. In current study immunoinformatics procedures were employed introduce a novel multi-epitope subunit vaccine. This can activate equally class I II leukocyte antigen antibody...

Journal: :Dermatology 1999
A Rebora F Rongioletti F Drago Parodi

Dr. Alfredo Rebora Department of Dermatology, University of Genoa Viale Benedetto XV I–16132 Genova (Italy) Tel. +39 10 353 8414, Fax +39 10 353 8401 Ferrando et al. [1] in this tissue of Dermatology report a further case of lichen planus (LP) occurring after vaccination against hepatitis B virus (HBV). We are aware of 18 cases [2–11], including 2 observed by us and still unpublished (table 1)....

2012
Guohong Ge Shixia Wang Yaping Han Chunhua Zhang Shan Lu Zuhu Huang

Although the use of recombinant hepatitis B virus surface (HBsAg) protein vaccine has successfully reduced global hepatitis B infection, there are still a number of vaccine recipients who do not develop detectable antibody responses. Various novel vaccination approaches, including DNA vaccines, have been used to further improve the coverage of vaccine protection. Our previous studies demonstrat...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید